Somatodendritic neuropeptide release potentiates GABAergic synapses in the VTA
Sep
28
2026
Sep
28
2026
Description
Dr. Julie Kauer is a Professor of Psychiatry & Behavioral Sciences at Stanford University.
Neuropeptides are contained in nearly every neuron in the central nervous system and can be released not only from nerve terminals but also from somatodendritic sites. Cholecystokinin (CCK), among the most abundant neuropeptides in the brain, is expressed in the majority of midbrain dopamine neurons. Despite this high expression, CCK function within the ventral tegmental area (VTA) is not well understood. We found that VTA dopamine neurons release CCK from somatodendritic regions, where it triggers long-term potentiation of GABAergic synapses. The somatodendritic release occurs during trains of optogenetic stimuli or prolonged but modest depolarization. Paired-recording experiments demonstrated that CCK released from a single dopamine neuron is sufficient to induce LTP in synapses on neighboring neurons, suggesting that somatodendritic CCK release may influence a substantial fraction of nearby dopamine neurons and coordinate plasticity across local ensembles rather than acting in a strict cell- or synapse-autonomous manner. In vivo, intra-VTA–infused CCK reduced dopamine cell Ca2+ signals during food consumption and was correlated with reduced food intake. Our experiments introduce somatodendritic neuropeptide release as a previously unknown feedback regulator of VTA dopamine cell excitability and support the idea that peptide signaling adds complexity and richness to neural circuits.
Hosted by Dr. Lief Fenno
To subscribe to our Seminars Series mailing list, please visit https://utlists.utexas.edu/sympa/info/neu-seminars and click on "Subscribe" in the left-hand column.
Please contact Neuro.Seminar.Series@austin.utexas.edu with any questions.
Other Events in This Series
Sep
14
2026
Control of population spiking activity in prefrontal cortex using microstimulation
2026-27 Neuroscience Seminar Series
3:00 pm – 4:00 pm • In Person
Speaker(s): Luca Mazzucato - University of Oregon
Sep
21
2026
From bench to bedside: mechanisms of long-term memory inform the development of novel treatments for neurodevelopmental disorders and neurodegenerative diseases
2026-27 Neuroscience Seminar Series
3:00 pm – 4:00 pm • In Person
Speaker(s): Christina Alberini - New York University
Nov
2
2026
Cengiz Pehlevan - Title TBA
2026-27 Neuroscience Seminar Series
3:00 pm – 4:00 pm • In Person
Speaker(s): Cengiz Pehlevan - Harvard University
Nov
9
2026
Scents and Sense-ability
2026-27 Neuroscience Seminar Series
3:00 pm – 4:00 pm • In Person
Speaker(s): Denise Ferkey - University of Buffalo
Dec
7
2026
Valeria Vasquez - Title TBA
2026-27 Neuroscience Seminar Series
3:00 pm – 4:00 pm • In Person
Speaker(s): Valeria Vasquez - UTHSC at Houston
Jan
11
2027
D. Kacy Cullen - Title TBA
2026-27 Neuroscience Seminar Series
3:00 pm – 4:00 pm • In Person
Speaker(s): D. Kacy Cullen - University of Pennsylvania
Jan
25
2027
Loren Frank - Title TBA
2026-27 Neuroscience Seminar Series
3:00 pm – 4:00 pm • In Person
Speaker(s): Loren Frank - UCSF
Feb
8
2027
David Perkel - Title TBA
2026-27 Neuroscience Seminar Series
3:00 pm – 4:00 pm • In Person
Speaker(s): David J. Perkel - University of Washington
Feb
22
2027
Ethan Hughes - Title TBA
2026-27 Neuroscience Seminar Series
3:00 pm – 4:00 pm • In Person
Speaker(s): Ethan Hughes - University of Colorado
Mar
1
2027
Morgan Barense - Title TBA
2026-27 Neuroscience Seminar Series
3:00 pm – 4:00 pm • In Person
Speaker(s): Morgan Barense - University of Toronto